These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34415439)

  • 1. Neurochemical properties measured by
    Ivarsson T; Melin K; Carlsson Å; Ljungberg M; Forssell-Aronsson E; Starck G; Skarphedinsson G
    J Neural Transm (Vienna); 2021 Sep; 128(9):1361-1370. PubMed ID: 34415439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.
    O'Neill J; Gorbis E; Feusner JD; Yip JC; Chang S; Maidment KM; Levitt JG; Salamon N; Ringman JM; Saxena S
    J Psychiatr Res; 2013 Apr; 47(4):494-504. PubMed ID: 23290560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
    O'Neill J; Piacentini JC; Chang S; Levitt JG; Rozenman M; Bergman L; Salamon N; Alger JR; McCracken JT
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):161-8. PubMed ID: 21983143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.
    O'Neill J; Piacentini J; Chang S; Ly R; Lai TM; Armstrong CC; Bergman L; Rozenman M; Peris T; Vreeland A; Mudgway R; Levitt JG; Salamon N; Posse S; Hellemann GS; Alger JR; McCracken JT; Nurmi EL
    Neuropsychopharmacology; 2017 Nov; 42(12):2414-2422. PubMed ID: 28409563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes in neurometabolite concentrations in the dorsal anterior cingulate cortex after concentrated exposure therapy for obsessive-compulsive disorder.
    de Joode NT; Thorsen AL; Vester EL; Vriend C; Pouwels PJW; Hagen K; Ousdal OT; Hansen B; Kvale G; van den Heuvel OA
    J Affect Disord; 2022 Feb; 299():344-352. PubMed ID: 34920037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is glutamate associated with fear extinction and cognitive behavior therapy outcome in OCD? A pilot study.
    Giménez M; Cano M; Martínez-Zalacaín I; Real E; Alonso P; Segalàs C; Munuera J; Kegeles LS; Weinstein JJ; Xu X; Menchón JM; Cardoner N; Soriano-Mas C; Fullana MA
    Eur Arch Psychiatry Clin Neurosci; 2020 Dec; 270(8):1003-1014. PubMed ID: 31432262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive-compulsive disorder.
    Ljungberg M; Nilsson MKL; Melin K; Jönsson L; Carlsson A; Carlsson Å; Forssell-Aronsson E; Ivarsson T; Carlsson M; Starck G
    Acta Neuropsychiatr; 2017 Jun; 29(3):179-190. PubMed ID: 27772535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of orbitofrontal neurochemistry for the outcome of cognitive-behavioural therapy in patients with obsessive-compulsive disorder.
    Zurowski B; Kordon A; Weber-Fahr W; Voderholzer U; Kuelz AK; Freyer T; Wahl K; Büchel C; Hohagen F
    Eur Arch Psychiatry Clin Neurosci; 2012 Oct; 262(7):617-24. PubMed ID: 22427151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1H-MRS of the anterior cingulate cortex in childhood and adolescent obsessive-compulsive disorder: a case-control study.
    Ortiz AE; Ortiz AG; Falcon C; Morer A; Plana MT; Bargalló N; Lázaro L
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):60-8. PubMed ID: 25499604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity.
    Starck G; Ljungberg M; Nilsson M; Jönsson L; Lundberg S; Ivarsson T; Ribbelin S; Ekholm S; Carlsson A; Forssell-Aronsson E; Carlsson ML
    J Neural Transm (Vienna); 2008 Jul; 115(7):1051-62. PubMed ID: 18528631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.
    Simpson HB; Shungu DC; Bender J; Mao X; Xu X; Slifstein M; Kegeles LS
    Neuropsychopharmacology; 2012 Nov; 37(12):2684-92. PubMed ID: 22850733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional homogeneity of spontaneous brain activity in adult patients with obsessive-compulsive disorder before and after cognitive behavioural therapy.
    Yang XY; Sun J; Luo J; Zhong ZX; Li P; Yao SM; Xiong HF; Huang FF; Li ZJ
    J Affect Disord; 2015 Dec; 188():243-51. PubMed ID: 26378734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The right thalamic glutamate level correlates with functional connectivity with right dorsal anterior cingulate cortex/middle occipital gyrus in unmedicated obsessive-compulsive disorder: A combined fMRI and
    Chen Y; Meng Z; Zhang Z; Zhu Y; Gao R; Cao X; Tan L; Wang Z; Zhang H; Li Y; Fan Q
    Aust N Z J Psychiatry; 2019 Mar; 53(3):207-218. PubMed ID: 30354192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy.
    Benazon NR; Moore GJ; Rosenberg DR
    J Am Acad Child Adolesc Psychiatry; 2003 Nov; 42(11):1279-85. PubMed ID: 14566164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderators and predictors of outcomes in telephone delivered compared to face-to-face cognitive behaviour therapy for paediatric obsessive-compulsive disorder: preliminary evidence from a non-inferiority RCT.
    Nair A; Turner C; Heyman I; Mataix-Cols D; Lovell K; Krebs G; Lang K; Byford S; O'Kearney R
    Cogn Behav Ther; 2019 Sep; 48(5):353-368. PubMed ID: 30221589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Effects of Cognitive Behavioral Therapy on Planning and Prefrontal Cortex Function in Pediatric Obsessive-Compulsive Disorder.
    van der Straten A; Huyser C; Wolters L; Denys D; van Wingen G
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Apr; 3(4):320-328. PubMed ID: 29628064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paediatric Obsessive-Compulsive Disorder and Depressive Symptoms: Clinical Correlates and CBT Treatment Outcomes.
    Brown HM; Lester KJ; Jassi A; Heyman I; Krebs G
    J Abnorm Child Psychol; 2015 Jul; 43(5):933-42. PubMed ID: 25301176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can memory and executive functions in patients with obsessive-compulsive disorder predict outcome of cognitive behavioural therapy?
    Vandborg SK; Hartmann TB; Bennedsen BE; Pedersen AD; Thomsen PH
    Nord J Psychiatry; 2016; 70(3):183-9. PubMed ID: 26329120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of cognitive behavioural therapy with medication for patients with obsessive-compulsive disorder: A multicentre randomised controlled trial in China.
    Meng FQ; Han HY; Luo J; Liu J; Liu ZR; Tang Y; Hou X; Wei J; Shi LL; Tang MN; Yan YP; Huang YQ; Sun J; Li ZJ
    J Affect Disord; 2019 Jun; 253():184-192. PubMed ID: 31108379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-Cycloserine augmentation of cognitive behavior therapy for pediatric OCD: Predictors and moderators of outcome.
    Wilhelm S; Berman N; Small BJ; Porth R; Storch EA; Geller D
    J Affect Disord; 2018 Dec; 241():454-460. PubMed ID: 30149332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.